Income Taxes

9 Months Ended

Mar. 31, 2021

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The effective tax rate used for interim periods is the estimated annual effective consolidated tax rate, based on the current estimate of full year results, except that taxes related to specific events, if any, are recorded in the interim period in which they occur. The annual effective tax rate is based upon a number of significant estimates and judgments, including the estimated annual pre-tax income or loss of the Company in each tax jurisdiction in which it operates, and the development of tax planning strategies during the year. In addition, the Company’s tax expense or benefit can be impacted by changes in tax rates or laws, the finalization of tax audits, and other factors that cannot be predicted with certainty. As such, there can be significant volatility in interim tax provisions.

Income tax benefit for the three months ended March 31, 2021 was $16.7 million, or 29.2 percent of pre-tax loss as compared with income tax expense of $10.0 million, or 20.0 percent of pre-tax income for the three months ended March 31, 2020. Income tax benefit in the nine months ended March 31, 2021 was $46.4 million, or 21.2 percent of pre-tax loss as compared with income tax expense of $34.6 million, or 22.4 percent of pre-tax income for the nine months ended March 31, 2020.

Income tax benefit for the three months ended March 31, 2021 includes discrete tax benefits of $2.2 million associated with pension settlement charges, $1.8 million for the impact of restructuring and asset impairment charges and $0.8 million as a result of changes in the Company’s prior year tax positions. Additionally, the anticipated benefit for the carryback of the current year net operating loss to fiscal years with higher tax rates is included in this period. Also included are the unfavorable impacts of losses in certain foreign jurisdictions for which no tax benefit can be recognized. Excluding the discrete tax impacts of the pension settlement charges, restructuring and asset impairment charges and changes in the Company’s prior year tax position, the tax rate for the three months ended March 31, 2021 would have been 29.3%. Income tax expense in the three months ended March 31, 2020 included discrete tax benefits of $1.6 million as a result of changes in the Company’s prior year tax positions as well as the impact of losses in certain foreign jurisdictions for which no tax benefit can be recognized.

Income tax benefit for the nine months ended March 31, 2021 includes the unfavorable impacts of the $52.8 million non-deductible goodwill impairment charge and losses in certain foreign jurisdictions for which no tax benefit can be recognized, as well as, discrete tax benefits of $2.2 million associated with pension settlement charges, $2.0 million associated with debt extinguishment losses, net, $4.2 million for the impact of restructuring and asset impairment charges and $0.8 million as a result of changes in the Company’s prior year tax positions. Additionally, the anticipated benefit for the carryback of the current year net operating loss to fiscal years with higher tax rates is included in this period. Also included is a tax charge of $1.2 million attributable to employee share-based compensation. Excluding the discrete tax impacts of the non-deductible goodwill impairment charge, pension settlement charges, debt extinguishment losses, net, restructuring and asset impairment charges and changes in the Company’s prior year tax position, the tax rate for the nine months ended March 31, 2021 would have been 28.2 percent. Income tax expense in the nine months ended March 31, 2020 included discrete tax benefits of $1.6 million as a result of changes in the Company’s prior year tax positions and $0.5 million attributable to employee share-based compensation. Also included was the impact of losses in certain foreign jurisdictions for which no tax benefit can be recognized.

The Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) was enacted on March 27, 2020. The CARES Act established new provisions, including but not limited to, expanded deduction of certain qualified capital expenditures, delayed payment of certain employment taxes, expanded use of net operating losses, reduced limitations on deductions of interest expense and extension of funding for defined benefit plans. The net operating loss provision is expected to provide incremental tax benefits of approximately $7.0 million due to the higher tax rates in the expanded carryback period. The other provisions in the CARES Act are not expected to have a significant impact on our financial position, results of operations or cash flows.